000 01457 a2200397 4500
005 20250518035855.0
264 0 _c20200210
008 202002s 0 0 eng d
022 _a2373-2822
024 7 _a10.1523/ENEURO.0443-18.2019
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBornebusch, Annika Billefeld
245 0 0 _aGlucagon-Like Peptide-1 Receptor Agonist Treatment Does Not Reduce Abuse-Related Effects of Opioid Drugs.
_h[electronic resource]
260 _beNeuro
_c
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAlcoholism
_xdrug therapy
650 0 4 _aAnimals
650 0 4 _aBehavior, Animal
_xdrug effects
650 0 4 _aConditioning, Operant
_xdrug effects
650 0 4 _aExenatide
_xpharmacology
650 0 4 _aGlucagon-Like Peptide-1 Receptor
_xanalysis
650 0 4 _aHypoglycemic Agents
_xpharmacology
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aMice, Inbred C57BL
650 0 4 _aMice, Knockout
650 0 4 _aMotor Activity
_xdrug effects
650 0 4 _aOpioid-Related Disorders
_xdrug therapy
650 0 4 _aGlucagon-Like Peptide-1 Receptor Agonists
700 1 _aFink-Jensen, Anders
700 1 _aWörtwein, Gitta
700 1 _aSeeley, Randy J
700 1 _aThomsen, Morgane
773 0 _teNeuro
_gvol. 6
_gno. 2
856 4 0 _uhttps://doi.org/10.1523/ENEURO.0443-18.2019
_zAvailable from publisher's website
999 _c29660455
_d29660455